Skip to content

The Buckle BKE Payments to Acquire Marketable Securities

Payments to Acquire Marketable Securities at other companies

UMH
UMH PropertiesUMH
$7K0.0%
TRV
Trevi Therapeutics, Inc.TRVI
$8.49M-69.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$166.31M+0.8%
DJT
Trump Media & Technology GroupDJT
$1.93M
Zymeworks logo
ZymeworksZYME
$0-100%
Cavco Industries logo
Cavco IndustriesCVCO
$15.57M+139%

Other financials

Income statement

See full
Revenue$288.7M+6.1%
Gross profit$133.5M+5.1%
Operating income$59.5M+36.5%
Net income$46.9M+33.2%
EPS (diluted)$0.92+31.4%

Balance sheet

See full
Cash & equivalents$266.2M-1.0%
Total debt$410.9M+11.1%
Total equity$458.9M+3.1%
Total assets$1.0B+7.3%

Cash flow

See full
Operating cash flow$49.3M+59.2%
CapEx$14.7M+28.6%
Free cash flow$34.7M+77.1%

Valuation

See full
Market cap$2.3B+59.6%

Profitability

See full
Gross margin48.9%+0.1pp
Operating margin21.1%+1.3pp
Net margin16.8%+0.9pp
FCF margin16.8%+0.5pp

Returns & leverage

See full
Return on equity49%+4.4pp
Debt / equity0.9×+0.1×
Current ratio-0.1×

Where this comes from

Reported directly by The Buckle in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireMarketableSecurities.

The official record: The Buckle’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Buckle's payments to acquire marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Buckle's payments to acquire marketable securities?
The Buckle (BKE) reported payments to acquire marketable securities of $11.83M in Q1 2026.
How has The Buckle's payments to acquire marketable securities changed year-over-year?
The Buckle's payments to acquire marketable securities increased by 57.9% year-over-year, from $7.49M to $11.83M.